Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.
about
Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formationExpression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated deathPredictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.The role of cellular FLICE inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer.Expression of cellular FLICE-inhibitory protein and its association with p53 mutation in colon cancer.Cellular FLICE-inhibitory protein: an attractive therapeutic target?c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.Targeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma.Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.FLIP as an anti-cancer therapeutic target.Expression and biological significance of c-FLIP in human hepatocellular carcinomasTreatment of Hodgkin lymphoma: the past, present, and future.Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment.Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity.Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases.The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma.Caspase-8 and its inhibitors in RCCs in vivo: the prominent role of ARC.Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells.IkappaBalpha independent induction of NF-kappaB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells.cIAP2 is highly expressed in Hodgkin-Reed-Sternberg cells and inhibits apoptosis by interfering with constitutively active caspase-3.Rapid turnover of c-FLIPshort is determined by its unique C-terminal tail.FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis.FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells.Heat stress downregulates FLIP and sensitizes cells to Fas receptor-mediated apoptosis.C/EBPalpha or C/EBPalpha oncoproteins regulate the intrinsic and extrinsic apoptotic pathways by direct interaction with NF-kappaB p50 bound to the bcl-2 and FLIP gene promoters.Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin's lymphomaInvolvement of FLIP in 2-methoxyestradiol-induced tumor regression in transgenic adenocarcinoma of mouse prostate model.The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype.STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis.Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIPL in NK/T-cell lymphoma.c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications.Increased expression of FLIP, an inhibitor of Fas-mediated apoptosis, in stomach cancer.Apoptosis-resistant phenotype of classical Hodgkin's lymphoma is not mediated by somatic mutations within genes encoding members of the death-inducing signaling complex (DISC).Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin.cFLIP expression correlates with tumour progression and patient outcome in non-Hodgkin lymphomas of low grade of malignancyAnalysis of NF-κB Pathway Proteins in Pediatric Hodgkin Lymphoma: Correlations with EBV Status and Clinical Outcome—A Children's Oncology Group Study
P2860
Q28302520-E06A1456-1185-4B99-8C00-757F879447E5Q33696062-A5F0485D-DBF5-49FD-98FC-9652D6AD0AADQ34427649-20ED66FD-EB19-4F28-AB09-9162A85FA6D7Q34488806-D3A0EBE6-2B73-4AB1-A562-E36D39FEE337Q35010218-3730D3AA-A0F5-41AD-B07F-EF3EC32AECAFQ35186676-57D9240A-FCA5-4EE9-8B69-EF4B5719AB86Q36399443-3A999DB1-555C-443E-9FFF-EA1EEBD12094Q36500552-F5A56D14-C37D-4203-868C-FD97066C1A80Q37004635-E53CB77B-E51D-4095-9346-DC367CF00533Q37016499-3F996CF3-92B4-4831-8761-E14962F56472Q37096732-4935AE0F-65E6-41D3-BA9F-055A544C818BQ37126241-BC2F2945-C6B4-4C33-94D1-E9034A04662BQ37235019-04101E7F-7B96-4078-9516-8C782C45BB3BQ37271829-C040B980-FB8E-48C1-93BD-2FC87F80B1FCQ37515926-14F0E344-6744-4521-89AC-CF509F45C3E6Q38132359-3C7BC0FE-5395-4508-8C67-4661FD0EA123Q38353369-F6DFC89D-D546-4DD1-9AB8-34B1C780EFCFQ39663897-17D0B46B-A889-483F-AF09-A6479BE19CC2Q39976439-A796DCC1-D93C-41F3-8A1C-4D69012D5560Q39995306-1AF30C68-F27A-43FD-B8CC-A3D6AE56AD90Q40169298-CD9C793C-CEEB-4291-9D04-619AA6772114Q40347662-C92E9656-4872-489D-8BD8-9F606D1C5BC4Q40424237-4D173233-95B9-45C8-86D2-92577E2DF464Q40428505-C1E0180C-D421-46D1-99FB-F004E46F4D35Q40521494-E92A0498-9D1C-4B21-A2C5-BDEF353D66CAQ40549981-2D1315DB-3519-44EC-A19F-C437BE2E6596Q41839749-9C1E6D6A-BAD8-44D1-9F4D-AACB1D34152CQ41861924-6AC53773-3A4A-4B09-AE18-DB7D52B88E63Q42562681-ACB412D7-5827-4D00-A71B-37F56D586373Q43808409-BF23FE31-4A58-4083-BF81-E99BBD415EB9Q46506090-A4FB5168-A157-4452-825F-5B3466F8F91CQ46517064-1B5E722A-2BDD-4D73-9234-338B61E3B940Q52579698-551BABFF-2B9B-44E1-A998-5DDF881B3C0BQ53656208-0AAC6E6F-61EF-4D8B-8173-A8130E5F4E5BQ53861687-A251A553-5C25-45FA-8091-D28919A4E25FQ55469928-340675B9-F260-440D-BBCF-3A8B04D7681BQ57201231-E6F203E5-D432-46FE-BF4C-EE92DB6B9410Q58698930-97C06C85-5121-42FF-B171-39A69593F256
P2860
Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.
@ast
Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.
@en
type
label
Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.
@ast
Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.
@en
prefLabel
Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.
@ast
Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.
@en
P2093
P2860
P1476
Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.
@en
P2093
Andreas Draube
Anne Kallenborn
Claudia Wickenhauser
Jürgen Wolf
Martina Vockerodt
Roman Kurt Thomas
Volker Diehl
P2860
P304
P356
10.1016/S0002-9440(10)62578-3
P407
P577
2002-04-01T00:00:00Z